Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration

被引:137
作者
Berke, SJS [1 ]
Paulson, HL
机构
[1] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA
[2] Univ Iowa, Grad Program Neurosci, Paulson Lab EMRB 240, Iowa City, IA 52242 USA
关键词
D O I
10.1016/S0959-437X(03)00053-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Protein misfolding and aggregation are common to most neurodegenerative diseases, suggesting that abnormalities of protein homeostasis contribute to pathogenesis. Research implicates at least two components of cellular protein quality control in disease: molecular chaperones and the ubiquitin-proteasome pathway (UPP). Although evidence is more compelling for chaperone involvement, recent cell-based and genetic studies suggest that perturbations in the UPP also contribute to neurodegenerative disease processes. UPP involvement in disease seems even more probable when the UPP is viewed not simply as an isolated degradation machine but rather as a complex cascade linked both to other ubiquitin-dependent processes and to chaperone systems.
引用
收藏
页码:253 / 261
页数:9
相关论文
共 81 条
  • [31] Ataxin-1 nuclear localization and aggregation:: Role in polyglutamine-induced disease in SCA1 transgenic mice
    Klement, IA
    Skinner, PJ
    Kaytor, MD
    Yi, H
    Hersch, SM
    Clark, HB
    Zoghbi, HY
    Orr, HT
    [J]. CELL, 1998, 95 (01) : 41 - 53
  • [32] Aggresomes, inclusion bodies and protein aggregation
    Kopito, RR
    [J]. TRENDS IN CELL BIOLOGY, 2000, 10 (12) : 524 - 530
  • [33] Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins
    Krobitsch, S
    Lindquist, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) : 1589 - 1594
  • [34] Inhibition of the ubiquitin-proteasome system in Alzheimer's disease
    Lam, YA
    Pickart, CM
    Alban, A
    Landon, M
    Jamieson, C
    Ramage, R
    Mayer, RJ
    Layfield, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) : 9902 - 9906
  • [35] The ubiquitin pathway in Parkinson's disease
    Leroy, E
    Boyer, R
    Auburger, G
    Leube, B
    Ulm, G
    Mezey, E
    Harta, G
    Brownstein, MJ
    Jonnalagada, S
    Chernova, T
    Dehejia, A
    Lavedan, C
    Gasser, T
    Steinbach, PJ
    Wilkinson, KD
    Polymeropoulos, MH
    [J]. NATURE, 1998, 395 (6701) : 451 - 452
  • [36] Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation
    Lindsten, K
    de Vrij, FMS
    Verhoef, LGGC
    Fischer, DF
    van Leeuwen, FW
    Hol, EM
    Masucci, MG
    Dantuma, NP
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 157 (03) : 417 - 427
  • [37] The UCH-L1 gene encodes two opposing enzymatic activities that affect α-synuclein degradation and Parkinson's disease susceptibility
    Liu, YC
    Fallon, L
    Lashuel, HA
    Liu, ZH
    Lansbury, PT
    [J]. CELL, 2002, 111 (02) : 209 - 218
  • [38] The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome
    Lüders, J
    Demand, J
    Höhfeld, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) : 4613 - 4617
  • [39] Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects
    Luthi-Carter, R
    Strand, AD
    Hanson, SA
    Kooperberg, C
    Schilling, G
    La Spada, AR
    Merry, DE
    Young, AB
    Ross, CA
    Borchelt, DR
    Olson, JM
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (17) : 1927 - 1937
  • [40] Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol
    Ma, JY
    Wollmann, R
    Lindquist, S
    [J]. SCIENCE, 2002, 298 (5599) : 1781 - 1785